Farms.com Home   News

Survey Shows Low Crop Disease Risk In 2021

The province has completed its crop disease survey for 2021.

Manitoba Agriculture pathologist David Kaminski commented on canola.

"One of the diseases that is traditionally a problem for Manitoba is sclerotinia stem rot, also known as white mould in the other crops that are susceptible. It is the most substantial reduction. We saw virtually none this year."

Kaminski notes blackleg prevalence and severity was also down this year. He says the survey also showed no new cases of clubroot.

Disease in wheat was also low.

"In wheat, we see both foliar diseases and fusarium head blight. The latter is the one we're usually most concerned about. In 2020, we found it in a third of the fields. This year we have found it in less than one per cent of the fields."

Kaminski also commented on soybeans.

"We almost always see bacterial blight and soybean brown spot, with pretty high prevalence. For instance, in 2020, bacterial blight took the lead with 92 per cent of the fields surveyed and brown spot was found in 80 per cent of the fields. Not at really alarming intensity but still it was there. In our results so far from this year, we see more brown spot than bacterial blight, but brown spot is in a quarter of the fields and the severity is even less than last year."

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.